- Home
- POET vs NPCE Comparison
POET vs NPCE Comparison
Compare POET & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POET
- NPCE
- Stock Information
- Founded
- POET 1972
- NPCE 1997
- Country
- POET Canada
- NPCE United States
- Employees
- POET N/A
- NPCE N/A
- Industry
- POET Semiconductors
- NPCE Medical Specialities
- Sector
- POET Technology
- NPCE Health Care
- Exchange
- POET Nasdaq
- NPCE Nasdaq
- Market Cap
- POET 401.2M
- NPCE 417.9M
- IPO Year
- POET N/A
- NPCE 2021
- Fundamental
- Price
- POET $4.74
- NPCE $13.90
- Analyst Decision
- POET Strong Buy
- NPCE Buy
- Analyst Count
- POET 2
- NPCE 7
- Target Price
- POET $6.25
- NPCE $15.29
- AVG Volume (30 Days)
- POET 2.0M
- NPCE 176.0K
- Earning Date
- POET 03-14-2025
- NPCE 03-04-2025
- Dividend Yield
- POET N/A
- NPCE N/A
- EPS Growth
- POET N/A
- NPCE N/A
- EPS
- POET N/A
- NPCE N/A
- Revenue
- POET $119,946.00
- NPCE $76,452,000.00
- Revenue This Year
- POET N/A
- NPCE $23.82
- Revenue Next Year
- POET $9,744.96
- NPCE $14.31
- P/E Ratio
- POET N/A
- NPCE N/A
- Revenue Growth
- POET N/A
- NPCE 27.00
- 52 Week Low
- POET $1.00
- NPCE $5.45
- 52 Week High
- POET $7.79
- NPCE $18.15
- Technical
- Relative Strength Index (RSI)
- POET 45.38
- NPCE 61.09
- Support Level
- POET $4.00
- NPCE $13.21
- Resistance Level
- POET $5.21
- NPCE $15.04
- Average True Range (ATR)
- POET 0.39
- NPCE 0.99
- MACD
- POET -0.08
- NPCE -0.03
- Stochastic Oscillator
- POET 42.05
- NPCE 67.65
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The group's operations are located in Allentown, PA, Shenzhen, China, and Singapore.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.